Metabolic Study of Cockayne Syndrome
- Conditions
- Cockayne Syndrome
- Interventions
- Other: Metabolic evaluation
- Registration Number
- NCT03044210
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
Cockayne syndrome (CS) is related to defective DNA transcription and/or repair and belongs to the family of Nucleotide Excision Repair. It is an autosomal recessive multisystemic disorder characterized by mental retardation, microcephaly, severe growth failure with lipoatrophia, sensorial impairment, cutaneous photosensitivity, dental decay, enophtalmios. The disease is progressive causing severe impairments but there's currently no therapeutics for the disease.
Growth failure, feeding difficulties and lipoatrophia are prognostic keys of CS but physiopathology is unknown.
According to preliminary assays, our goal is to test the hypothesis that cachexia is due to hypometabolism. We also want to test the potential link between this basal metabolism modification and mitochondrial dysfunction and somatotrope axis, and correlation between the basal metabolism degree and global severity of the disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 25
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control subjects Metabolic evaluation Interventions performed: * urinary collection * metabolic evaluation * clinical evaluation Cockayne patients Metabolic evaluation Interventions performed: * blood sample * urinary collection * metabolic evaluation * clinical evaluation
- Primary Outcome Measures
Name Time Method Rest energetic cost measured by indirect calorimetry compared to calculated Black equation Day 0
- Secondary Outcome Measures
Name Time Method Rest energetic cost measured by indirect calorimetry compared to calculated theorical equations Day 0 Fat mass and lean mass measured by impedancemetry Day 0 Hormonal axis evaluation and mitochondrial activity measured by level of hormones and lactates/pyruvates in blood Day 0 Respiratory quotient measured by indirect calorimetry Day 0
Trial Locations
- Locations (1)
Centre d'Investigation Clinique
🇫🇷Strasbourg, France